. 2011 Jan 17;10(4):M110.004978. doi: 10.1074/mcp.M110.004978

Table II. Configuration of the four panels used for multiplex PLA biomarker screening.

Panel	1	2	3	4
Dilution	1:1	1:1	1:10	1:100
Sequence
1	Carbonic Anhydrase IX	Survivin	Spondin-2/Midin	Clusterin
2	MCP-1 (CCL2)	Desmin	EPCAM	No assay
3	Mesothelin	HGF R/cMET	NSE (enolase 2)	sP-selectin
4	IL-6	IL-17	Transaldolase 1	MMP-2
5	No assay	IL-23	No assay	MMP-9
6	oit1/FAM3D	FoxP3	Galectin-3	Tenascin-C
7	CEACAM 5 pAb	CEACAM 5 pAb	TIMP1	TIMP1
8	VEGF	CEACAM1	EGFR	CRP
9	No assay	TGFb1	TFF3	PAI-1/Serpin
10	No assay	TGFb3	u-PA	sVCAM/CD106
11	CEA mAb	KLK3 (PSA)	CEA mAb	IGF-I
12	CA125	Cystatin SN	Transferrin Rec. (CD71)	Cathepsin B
13	Her4	Prolactin	CA 15.3	Angiogenin
14	HGF/SF	DcR3	CA19–9	IGF2
15	FABP2	IL8	Tropomyosin (CH1)	Tetranectin
16	Oligo PCR^a	Oligo PCR^a	Oligo PCR^a	Oligo PCR^a
17	APC^a	APC^a	APC^a	APC^a
32	GFP^a	GFP^a	GFP^a	GFP^a
35	IL8	CTGF	OPN	Cystatin C
38	PE^a	PE^a	PE^a	PE^a
45	Her2	GDNF	MIF	IGFBP-1
51	Her3	Fractalkine	No assay	GRP78/HSPA5/BiP
53	TNFa	MIP-1	SLPI	Kallikrein 11
57	IL-1a	CA 242	S100A8	YKL-40

^a Internal control used for normalization and reaction quality control.